Positive Airway Pressure Devices Market is expected to reach US$ 10,544.70 Million by 2031

Positive Airway Pressure Devices Tubes Segment to Bolster Positive Airway Pressure Devices Market Growth During 2023–2031

According to our new research study on "Positive Airway Pressure Devices Market Forecast to 2031 – Global Analysis – by Product Type, Application, and End User," the market was valued at US$ 6,291.58 million in 2023 and is projected to reach US$ 10,544.70 million by 2031; it is anticipated to record a CAGR of 6.7% from 2023 to 2031. The positive airway pressure devices market trends, along with drivers and deterrents affecting the market growth, are emphasized in the report.

The increasing demand for positive airway pressure devices and the growing shift toward home healthcare are contributing to the growing positive airway pressure devices market size. However, product recall hampers the market growth. Further, technological advancements in positive airway pressure devices are expected to bring in new market trends in the coming years.   

Positive Airway Pressure Devices Market Share, by Region, 2023 (%)

Source: The Insight Partners Analysis

Increasing Incidences of Respiratory Diseases Bolsters Positive Airway Pressure Devices Market Growth

Positive airway pressure (PAP) devices help keep the airways open while sleeping and result in improved cognitive function and better sleep quality for patients suffering from sleep apnea and respiratory disorders. Innovative PAP devices, such as continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) have been introduced in the market to address the growing need to treat patients with respiratory diseases. The demand for these devices is driven by the rising awareness and diagnosis of sleep apnea, especially obstructive sleep apnea (OSA). The demand is further fueled by the increasing incidence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD). For example, according to the American Lung Association, 11.7 million adults, or 4.6% of the population, had COPD in 2022. According to an article published in the European Respiratory Journal in 2020, 36,580,965 Europeans were reported to have COPD, which is projected to reach 49,453,852 by 2050, representing a 35.2% relative increase. Thus, owing to the benefits offered by PAP devices and the increasing incidences of respiratory diseases, the medical and respiratory care market for PAP devices is witnessing noticeable growth.

The positive airway pressure devices market analysis has been carried out by considering the following segments: product type, application, end user, and geography.

Based on product type, the market is segmented into CPAP devices, APAP devices, and BiPAP devices. The CPAP segment held the largest positive airway pressure devices market share in 2023. Continuous positive airway pressure (CPAP) therapy is a commonly used treatment for obstructive sleep apnea. A CPAP machine has a hose connected to a mask or nosepiece to deliver consistent, steady air pressure, which helps in breathing while sleeping. The prevalence of sleep apnea is increasing globally due to obesity and a sedentary lifestyle, leading to a growing demand for CPAP devices. CPAP device manufacturers offer a range of products, including standalone devices, combination devices [CPAP and bilevel positive airway pressure (BiPAP)], and portable devices.

CPAP devices significantly improve sleep quality and may reduce the risk of stroke. With the help of CPAP therapy over an extended period, the chances of various heart problems, such as congestive heart failure, coronary artery disease, and irregular heartbeat, can be remarkably reduced. Some other benefits of CPAP devices include alertness during the daytime, concentration, emotional stability, and low medical expenses. Koninklijke Philips N.V.; Devilbiss Healthcare LLC; 3B Medical, Inc.; and ResMed, Inc are among the popular CPAP device manufacturers.

By application, the market is categorized into chronic obstructive pulmonary disease, obstructive sleep apnea, and respiratory distress. The obstructive sleep apnea segment held the largest share of the market in 2023. PAP devices are commonly used to treat obstructive sleep apnea, a condition marked by frequent episodes of shallow or paused breathing during sleep. These devices operate by delivering a continuous stream of air pressure into the patient's airway to keep it open and prevent breathing from getting paused.

The growing prevalence of obstructive sleep apnea worldwide is fueling the global PAP device market. According to the data released by the American Medical Association in April 2022, an estimated 30 million people in the US had sleep apnea, of which only 6 million were diagnosed. PAP devices are proven to be an effective treatment for obstructive sleep apnea demonstrating significant improvements in symptoms and quality of life.

Further, market players are adopting organic growth strategies for market development. For instance, in August 2021, ResMed introduced the AirSense 11, its latest CPAP machine, featuring a range of new functions to address obstructive sleep apnea.

Based on end user, the positive airway pressure devices market is categorized into hospitals, ambulatory surgical centers, and home care rehabilitation centers. The hospitals and specialty clinics segment dominated the market in 2023. Hospitals are primary contact points for patients for the diagnosis and treatment of various conditions. Infrastructure available in hospitals helps professionals provide high-quality care for patients. The hospitals segment is expected to hold a considerable share due to high patient visits. Multispecialty hospitals offer diagnostic and therapeutic services for various sleep disorders. Moreover, hospitals help patients through reimbursement provisions and assistance.

The demand for PAP devices in hospitals is rising due to increasing awareness of sleep apnea and the effectiveness of PAP therapy in treating respiratory conditions. Hospitals such as Johns Hopkins Hospital (Baltimore, Maryland); Massachusetts General Hospital (Boston, Massachusetts); University of California, Los Angeles (UCLA) Medical Center (Los Angeles, California); and Duke University Health System (Durham, North Carolina) use PAP devices for treating sleep apnea and other respiratory conditions.

The geographic scope of the positive airway pressure devices market report includes the assessment of the market performance in North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), South & Central America (Brazil, Argentina, and the Rest of South & Central America), and the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com